{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:51:34Z","timestamp":1783075894691,"version":"3.54.6"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.euroneuro.2017.01.009","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T04:30:33Z","timestamp":1485318633000},"page":"205-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Dried Blood Spot sampling in psychiatry: Perspectives for improving therapeutic drug monitoring"],"prefix":"10.1016","volume":"27","author":[{"given":"Lisa C.","family":"Martial","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob E.","family":"Aarnoutse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnt","family":"Schellekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.M.","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aart H.","family":"Schene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Batalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2017.01.009_bib1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2165\/00003495-200363080-00002","article-title":"Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs?","volume":"63","author":"Aarnoutse","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1365\/s10337-010-1569-y","article-title":"A simple dried blood spot assay for therapeutic drug monitoring of lamotrigine","volume":"71","author":"Aburuz","year":"2010","journal-title":"Chromatographia"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib3","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, 2013. Diagnostic and Statistical Manual of Mental Disorders: DSM-5, fifth ed., Washington, DC.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1515\/cclm-2014-0472","article-title":"Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots","volume":"53","author":"Baldelli","year":"2015","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2125.2010.03815.x","article-title":"Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients","volume":"71","author":"Barraclough","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib6","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1007\/s00216-014-7619-9","article-title":"Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots for TDM purposes, using LC-MS\/MS","volume":"406","author":"Berm","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4155\/bio.15.255","article-title":"A clinical validation study for application of DBS in therapeutic drug monitoring of antidepressants","volume":"8","author":"Berm","year":"2016","journal-title":"Bioanalysis"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.talanta.2014.10.041","article-title":"A simple dried blood spot method for therapeutic drug monitoring of the tricyclic antidepressants amitriptyline, nortriptyline, imipramine, clomipramine, and their active metabolites using LC\u2013MS\/MS","volume":"134","author":"Berm","year":"2015","journal-title":"Talanta"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12281-015-0224-3","article-title":"Fundament and prerequisites for the application of an antifungal TDM service","volume":"9","author":"Bruggemann","year":"2015","journal-title":"Curr. Fungal Infect. Rep."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1021\/ac303014b","article-title":"Prediction of the hematocrit of dried blood spots via potassium measurement on a routine clinical chemistry analyzer","volume":"85","author":"Capiau","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib12","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1128\/JCM.02392-15","article-title":"Performance of an early infant diagnostic test, AmpliSens DNA-HIV-FRT, using dried blood spots collected from children born to human immunodeficiency virus-infected mothers in Ukraine","volume":"53","author":"Chang","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib13","unstructured":"Clinical and Laboratory Standards Institute, 2013. Measurement Procedure Comparison and Bias Estimation Using Patient Samples. EP09-A3."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib14","unstructured":"DBS Technology, 2015. \u3008http:\/\/dbs-system.ch\/technology\/\u3009. (Date accessed: 23-11)."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib15","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.1007\/s00216-014-8114-z","article-title":"Potassium-based algorithm allows correction for the hematocrit bias in quantitative analysis of caffeine and its major metabolite in dried blood spots","volume":"406","author":"De Kesel","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib16","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s00216-009-3412-6","article-title":"Use of the dried blood spot sampling process coupled with fast gas chromatography and negative-ion chemical ionization tandem mass spectrometry: application to fluoxetine, norfluoxetine, reboxetine, and paroxetine analysis","volume":"396","author":"Deglon","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib17","unstructured":"European Medicines Agency, 2011. Guideline on bioanalytical method validation. EMEA\/CHMP\/EWP\/192217\/2009."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib18","series-title":"Guidance for Industry. Bioanalytical Method Validation","author":"Food and Drug Administration","year":"2001"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2174\/1567201812666151029100909","article-title":"Consensus guideline based therapeutic drug monitoring (TDM) in psychiatry and neurology","volume":"13","author":"Hiemke","year":"2016","journal-title":"Curr. drug Deliv."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib21","first-page":"1","article-title":"Application of dried blood spots to determine vitamin D status in a large nutritional study with unsupervised sampling: the Food4Me project","author":"Hoeller","year":"2015","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib22","unstructured":"Holmes, D.T., 2015. Deming and Passing Bablok Regression in R. R-Bloggers.com. \u3008http:\/\/www.r-bloggers.com\/deming-and-passing-bablok-regression-in-r\/\u3009 (Date accessed: 18-07-2016)."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib23","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/bmc.3217","article-title":"Gas chromatography\u2013electron ionization\u2013mass spectrometry quantitation of valproic acid and gabapentin, using dried plasma spots, for therapeutic drug monitoring in in-home medical care","volume":"28","author":"Ikeda","year":"2014","journal-title":"Biomed. Chromatogr.: BMC"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib24","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.4155\/bio.14.185","article-title":"Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review","volume":"6","author":"Jager","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10549-014-2999-2","article-title":"Use of dried blood spots for the determination of serum concentrations of tamoxifen and endoxifen","volume":"146","author":"Jager","year":"2014","journal-title":"Breast cancer Res. Treat."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib26","doi-asserted-by":"crossref","first-page":"e108190","DOI":"10.1371\/journal.pone.0108190","article-title":"Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy","volume":"9","author":"Kong","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jchromb.2013.02.035","article-title":"Analysis of tacrolimus and creatinine from a single dried blood spot using liquid chromatography tandem mass spectrometry","volume":"926","author":"Koop","year":"2013","journal-title":"J. Chromatogr. B, Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib28","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00216-014-8415-2","article-title":"Dried blood spot analysis of creatinine with LC\u2013MS\/MS in addition to immunosuppressants analysis","volume":"407","author":"Koster","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.coph.2015.07.002","article-title":"Drug-interactions of azole antifungals with selected immunosuppressants in transplant patients: strategies for optimal management in clinical practice","volume":"24","author":"Lempers","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/bmc.1367","article-title":"Dried blood spot sampling in combination with LC\u2013MS\/MS for quantitative analysis of small molecules","volume":"24","author":"Li","year":"2010","journal-title":"Biomed. Chromatogr.: BMC"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib31","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/rcm.6212","article-title":"The use of a membrane filtration device to form dried plasma spots for the quantitative determination of guanfacine in whole blood","volume":"26","author":"Li","year":"2012","journal-title":"Rapid Commun. Mass Spectrom.: RCM"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib32","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.4155\/bio.15.99","article-title":"A LC-MS\/MS method for therapeutic drug monitoring of carbamazepine, lamotrigine and valproic acid in DBS","volume":"7","author":"Linder","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib33","doi-asserted-by":"crossref","unstructured":"Martial, L.C., Jacobs, B.A., Cornelissen, E.A., de Haan, A.F., Koch, B.C., Burger, D.M., Aarnoutse, R.E., Schreuder, M.F., Bruggemann, R.J., 2016.\u00a0Pharmacokinetics and target attainment of mycophenolate in pediatric renal transplant patients. Pediatric Transplantation.","DOI":"10.1111\/petr.12695"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib34","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.4155\/bio.15.133","article-title":"A new DBS card with spot sizes independent of the hematocrit value of blood","volume":"7","author":"Mengerink","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib35","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.4155\/bio.14.3","article-title":"Dried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patients","volume":"6","author":"Mercolini","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.euroneuro.2015.01.016","article-title":"Learning from the past and looking to the future: emerging perspectives for improving the treatment of psychiatric disorders","volume":"25","author":"Millan","year":"2015","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4172\/2155-9872.1000162","article-title":"An on-card approach for assessment of hematocrit on dried blood spots which allows for correction of sample volume","volume":"4","author":"Miller","year":"2013","journal-title":"J Anal. Bioanal. Tech."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejps.2015.04.008","article-title":"Dried blood spots for monitoring and individualization of antiepileptic drug treatment","volume":"75","author":"Milosheska","year":"2015","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib39","unstructured":"National Institute for Health and Care Excellence, 2014a. Bipolar disorder: assessment and management. \u3008http:\/\/nice.org.uk\/guidance\/cg185\u3009 (Data accessed: 05-2016)."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib40","unstructured":"National Institute for Health and Care Excellence, 2014b. Psychosis and schizophrenia in adults: prevention and management. \u3008http:\/\/nice.org.uk\/guidance\/cg178\u3009 (Data accessed: 05.2016)."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib41","unstructured":"National Institute for Health and Care Excellence, 2016. Depression in adults: recognition and management. \u3008http:\/\/nice.org.uk\/guidance\/cg90\u3009 (Data accessed: 05.2015)."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib42","unstructured":"Nederlandse Vereniging voor Psychiatrie, 2012. Multidisciplinaire richtlijn schizofrenie. \u3008http:\/\/www.nvvp.net\/website\/richtlijnen\/overzicht-richtlijnen\u3009 (Data accessed: 05.2016)."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib43","unstructured":"Nederlandse Vereniging voor Psychiatrie, 2013. Multidisciplinaire richtlijn depressie. \u3008http:\/\/www.nvvp.net\/website\/richtlijnen\/overzicht-richtlijnen\u3009 (Data accessed: 05.2016)."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib44","unstructured":"Nederlandse Vereniging voor Psychiatrie, 2015. Multidisciplinaire richtlijn bipolaire stoornissen. \u3008http:\/\/www.nvvp.net\/website\/richtlijnen\/overzicht-richtlijnen\u3009 (Data accessed: 05.2016)."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib45","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/jcp.24.6.576","article-title":"Estimation of blood phenylalanine from a dried blood spot using the Guthrie test","volume":"24","author":"Newman","year":"1971","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib46","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1177\/0269881108100320","article-title":"Psychiatrists\u05f3 attitude towards and knowledge of clozapine treatment","volume":"24","author":"Nielsen","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib47","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.4155\/bio.15.100","article-title":"Are capillary DBS applicable for therapeutic drug monitoring of common antipsychotics? A proof of concept","volume":"7","author":"Patteet","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib48","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/dta.1698","article-title":"The use of dried blood spots for quantification of 15 antipsychotics and 7 metabolites with ultra-high performance liquid chromatography\u2013tandem mass spectrometry","volume":"7","author":"Patteet","year":"2015","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib49","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3109\/00365513.2014.933360","article-title":"Quantification of valproic acid in dried blood spots","volume":"74","author":"Pohanka","year":"2014","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib50","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jpba.2014.03.044","article-title":"Simple procedure for determination of valproic acid in dried blood spots by gas chromatography\u2013mass spectrometry","volume":"96","author":"Rhoden","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib51","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/j.chroma.2011.01.071","article-title":"Rapid assays of clozapine and its metabolites in dried blood spots by liquid chromatography and microextraction by packed sorbent procedure","volume":"1218","author":"Saracino","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib52","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchromb.2013.02.005","article-title":"A simple bioanalytical method for the quantification of antiepileptic drugs in dried blood spots","volume":"923\u2013924","author":"Shah","year":"2013","journal-title":"J. Chromatogr. B, Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01060893","article-title":"Some suggestions for measuring predictive performance","volume":"9","author":"Sheiner","year":"1981","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib54","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpba.2015.02.045","article-title":"Therapeutic drug monitoring of carbamazepine and its metabolite in children from dried blood spots using liquid chromatography and tandem mass spectrometry","volume":"109","author":"Shokry","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib55","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/infdis\/jiv423","article-title":"Dried blood spots: a tool to ensure broad access to hepatitis C screening, diagnosis, and treatment monitoring","volume":"213","author":"Soulier","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib56","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4155\/bio.14.310","article-title":"A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocrit","volume":"7","author":"Spooner","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib57","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.4155\/bio.15.139","article-title":"DBS and beyond","volume":"7","author":"Stove","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.euroneuro.2017.01.009_bib58","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpba.2012.11.044","article-title":"The stability of amitriptyline N-oxide and clozapine N-oxide on treated and untreated dry blood spot cards","volume":"76","author":"Temesi","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib59","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.ftd.0000211810.19935.44","article-title":"Beyond cyclosporine: a systematic review of limited sampling strategies for other immunosuppressants","volume":"28","author":"Ting","year":"2006","journal-title":"Ther. drug Monit."},{"key":"10.1016\/j.euroneuro.2017.01.009_bib60","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s40262-014-0177-7","article-title":"Therapeutic drug monitoring by dried blood spot: progress to date and future directions","volume":"53","author":"Wilhelm","year":"2014","journal-title":"Clin. Pharmacokinet."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X17300238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X17300238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T23:26:47Z","timestamp":1568762807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X17300238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0924977X17300238"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2017.01.009","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dried Blood Spot sampling in psychiatry: Perspectives for improving therapeutic drug monitoring","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2017.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}